KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Other Non-Current Liabilities (2016 - 2025)

Boston Scientific's Other Non-Current Liabilities history spans 16 years, with the latest figure at $2.4 billion for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 28.61% year-over-year to $2.4 billion; the TTM value through Dec 2025 reached $2.4 billion, up 28.61%, while the annual FY2025 figure was $2.4 billion, 28.61% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $2.4 billion at Boston Scientific, up from $403.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $2.4 billion in Q4 2025 and bottomed at $63.0 million in Q1 2022.
  • The 5-year median for Other Non-Current Liabilities is $557.0 million (2021), against an average of $1.0 billion.
  • The largest annual shift saw Other Non-Current Liabilities plummeted 88.69% in 2022 before it surged 2062.22% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $486.0 million in 2021, then fell by 10.7% to $434.0 million in 2022, then fell by 6.91% to $404.0 million in 2023, then surged by 362.87% to $1.9 billion in 2024, then increased by 28.61% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Other Non-Current Liabilities are $2.4 billion (Q4 2025), $403.0 million (Q3 2025), and $744.0 million (Q2 2025).